期刊文献+

肝癌组织相关基因表达与肝癌术后生存的关系 被引量:2

Relationship between HCC-related genes expression in tumor tissue and postoperative survival of patients with hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨肝癌组织内多个肝癌相关基因表达情况及其与术后生存预后的关系。方法对72例手术切除肝癌患者的追踪随访资料进行生存分析,分析各临床和病理指标与生存预后的关系。对手术切除的肝癌标本以半定量RT-PCR方法测定癌组织中多个基因的表达情况。结果术前肝功能分级、血清AFP、AFU、癌组织分化程度、有无癌栓与预后相关(P<0.05)。肝癌组织内COL1A2、Gem in in、IGFBP3、SPINK2表达与患者的癌组织分化程度相关。结论肝癌组织内COL1A2、Gem in in、IGFBP3和SPINK2基因表达为肝癌术后生存的主要相关分子生物学因素。 Objective To investigate the relationship between HCC-related gene expression and postoperative survival of patients with hepatocellular carcinoma. Methods Survival analysis was used to analyze the follow-up data of 72 cases with hepatocellular carcinoma (HCC) postoperation. Semiquantitative reverse transcription polymerase chain reaction ( RT-PCR) was performed to test the expression of 10 genes in tumor tissue. Results Child.grades of liver function, serum AFP levels, AFU, tumor thrombosis and the degrees of histological differentiation were involved with prognosis. Tumor thrombosis and the degrees of histological differentiation were the independent factors affecting the survival after operation. The expression of COL1A2, Geminin, IGFBP3 and SPINK2 was related to the histological differentiation. Conclusion The expression levels of COL1A2, Geminin, IGFBP3 and SPINK2 in liver cancer are the main factors affecting the postoperative survival time.
出处 《山东医药》 CAS 北大核心 2008年第14期11-12,共2页 Shandong Medical Journal
基金 天津市科委攻关项目(05YFSZSF02500)
关键词 肝细胞 术后 生存 基因表达 carcinoma, hepatocellular postperation survival gene expression
  • 相关文献

参考文献4

二级参考文献22

  • 1李旋.影响肝癌门静脉癌栓因素的探讨[J].肝胆外科杂志,1995,3(3):160-161. 被引量:8
  • 2赵挺.合并门静脉癌栓的中、晚期原发性肝癌38例临床诊治分析[J].实用肿瘤杂志,1996,11(4):166-168. 被引量:8
  • 3安一明,刘倩,陈少华,张信,黄国英,李党生.血液流变性改变对肝癌门静脉癌栓形成的影响[J].微循环学杂志,1996,6(4):36-37. 被引量:6
  • 4Zorzos HS,Lazaris AC,Korkolopoulou PA,et al.Multidrug resistance proteins and topoisomerase Ⅱ alpha expression in colon cancer:association with metastatic potential[J].Pathology,2003,35(4):315-318.
  • 5Giaccone G,van Ark-Otte J,Scagliotti G,et al.Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung[J].Biochim Biophys Acta,1995,1264 (3):337-346.
  • 6Nakopoulou L,Lazaris AC,Kavantzas N,et al.DNA topoisomerase Ⅱ-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer[J].Pathobiology,2000,68(3):137-143.
  • 7Watanuki A,Ohwada S,Fukusato T,et al.Prognostic significance of DNA topoisomerase Ⅱalpha expression in human hepatocellular carcinoma[J].Anticancer Res,2002,22 (2B):1113-1119.
  • 8R. G. Simonetti,A. Liberati,C. Angiolini,L. Pagliaro. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials[J] 1997,Annals of Oncology(2):117~136
  • 9Thomas Lehnert M.D.,Gerd Otto M.D.,Christian Herfarth M.D.. Therapeutic modalities and prognostic factors for primary and secondary liver tumors[J] 1995,World Journal of Surgery(2):252~263
  • 10Nagahisa Fujio M.D.,Katsuji Sakai M.D.,Hiroaki Kinoshita M.D.,Kazuhiro Hirohashi M.D.,Shoji Kubo M.D.,Ryutaro Iwasa M.D.,Kwang Choon Lee M.D.. Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver[J] 1989,World Journal of Surgery(2):211~217

共引文献11

同被引文献20

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部